Lonza Guangzhou Pharmaceutical Ltd. | 10/31/25 | 483
Similar Posts
FDA Information Session on Generic Drug Research Needs & Opportunities for FY 2026 – 01/21/2026
FDA is hosting a virtual Information Session on Generic Drug Research Needs & Opportunities for fiscal year (FY) 2026 on Wednesday, January 21, 2026.PlantBased Innovations Issues Allergy Alert on Undeclared Almond in H-E-B Dairy-Free Coconut Yogurt, Strawberry Flavor
PlantBased Innovations, of Leominster, MA, is recalling Higher Harvest by H-E-B Dairy-Free Coconut Yogurt, Strawberry flavor because the product may contain undeclared almond. People who have an allergy or severe sensitivity to almonds run the risk of serious or life-threatening allergic reaction ifMeta Forte contains hidden drug ingredients
The Food and Drug Administration is advising consumers not to purchase or use Meta Forte, a product promoted and sold for sexual enhancement on various websites, and possibly in some retail stores.First Generic Drug Approvals
Each year, FDA’s Center for Drug Evaluation and Research (CDER) approves a wide range of new drug products. FDA provides the scientific and regulatory advice needed to bring safe, effective, high-quality generic alternatives to market, which in turn creates more affordable treatment options for patiSafe Use Initiative – Current Projects
Part of Safe Use Initiative
(updated)CDER Quantitative Medicine Center of Excellence (QM CoE)
The Center for Drug Evaluation and Research Quantitative Medicine Center of Excellence is established to facilitate and coordinate the continuous evolution and consistent application of quantitative medicine for drug development and regulatory decision-making across CDER.
